BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 108470
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.108470
Table 1 The clinicopathological characteristics of the Surveillance, Epidemiology, and End Results cohort and the Chinese cohort, n (%)
Characteristics
SEER database
Chinese registry
Total327423153
Examined lymph node, median (IQR)20.00 (15.00, 26.00)18.00 (15.00, 22.00)
Chemotherapy
No28228 (86.2)1429 (45.3)
Yes4514 (13.8)1724 (54.7)
Size, median (IQR)5.00 (3.80, 7.00)5.00 (4.00, 6.50)
Age
≥ 6522829 (69.7)1269 (40.2)
20-649913 (30.3)1884 (59.8)
Sex
Female17156 (52.4)1345 (42.7)
Male15586 (47.6)1808 (57.3)
Grade
Grade 1/226221 (80.1)2758 (87.5)
Grade 3/46521 (19.9)395 (12.5)
Histology
Adenocarcinoma27996 (85.5)2683 (85.1)
Mucinous adenocarcinoma4222 (12.9)425 (13.5)
Others524 (1.6)45 (1.4)
T stage
T327920 (85.3)2234(70.9)
T44822 (14.7)919 (29.1)


Write to the Help Desk